NCT00883506已完成1 期
Randomized, 3-Way Crossover, Bioequivalence Study of Eon Labs Manufacturing Inc. (USA) and Zeneca (USA) (Zestril) 40 mg Lisinopril Tablet Administered as a 1 x 40 mg Tablet in Health Adult Males Under Fasting Conditions Under Fasting and Fed Conditions.
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Sandoz
- 入组人数
- 24
- 主要终点
- Bioequivalence based on AUC and Cmax
研究概览
简要总结
To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet under Fasting and Fed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
排除标准
- •Positive test results for HIV or hepatitis B or C.
- •Treatment for drug or alcohol dependence.
研究组 & 干预措施
1
Experimental
Lisinopril 40 mg Tablet under fed conditions.
干预措施: Lisinopril 40 mg Tablet under fed conditions. (Drug)
2
Active Comparator
Lisinopril 40 mg Tablet (Zestril)
干预措施: Lisinopril 40 mg Tablet (Zestril) under fed conditions. (Drug)
3
Experimental
Lisinopril 40 mg Tablet under fasting conditions.
干预措施: Lisinopril 40 mg Tablet under fasting conditions. (Drug)
结局指标
主要结局
Bioequivalence based on AUC and Cmax
时间窗: 50 days
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting ConditionsHypertensionNCT00883064Sandoz32
已完成
1 期
A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)HealthyNCT02507648Genuine Research Center, Egypt24
已完成
1 期
A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)HealthyNCT02479867Genuine Research Center, Egypt24
已完成
1 期
A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)HealthyNCT02519010Genuine Research Center, Egypt36
已完成
1 期
A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)HealthyNCT02491450Genuine Research Center, Egypt24